Earnings Ahead

SGEN - Seattle Genetics

196.48 -0.06 -0.03

Seattle Genetics

Seattle Genetics

About

Profile

Founded 20 years ago, Seattle Genetics was built on a foundation of scientific innovation, rigorous research and drug development practices, as well as a passion for helping patients. Our leadership in antibody-drug conjugates (ADCs) and focus on innovati


Headquarters

Bothell, Washington, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

SGEN



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Seagen GAAP EPS of -$1.15 misses by $0.37, revenue of $571M misses by $64.1M
  • Pfizer CEO expects Seagen deal to close before year end, or early in 2024
  • Seattle Genetics Q3 2023 Earnings Preview
  • Pharma, PBMs spar over rising drug costs amid public scrutiny
  • Seagen, Genmab update Phase 3 data for uterine cancer therapy
  • Seagen/ Astellas succeed in Phase 3 trial for bladder cancer therapy
  • Seagen ticks higher as EU approves $43B sale to Pfizer
  • Pfizer likely turned over all documents to FTC for Seagen acquistion - report
  • Catalyst watch: Tesla earnings, Jerome Powell speech, UAW drama and Baidu event
  • Regulators looking at impact on innovation in review of Seagen/Pfizer - report
  • Pfizer expected to certify compliance with FTC on Seagen deal in 2-3 weeks - report
  • Merck succeeds in Phase 3 trial for bladder cancer therapy
  • Catalyst watch: Microsoft, Amazon, Oracle, and Intel to Hold High-Profile Events
  • 7 stocks to watch on Friday: Detroit Three automakers, Unity Software and more
  • Pfizer's $43B deal for Seagen gets European Union review
  • Seagen, Genmab succeed in Phase 3 trial for cervical cancer therapy
  • Horizon Therapeutics gains afer FTC settles with Amgen over $28B deal (update)
  • Horizon Therapeutics jumps after FTC pauses Amgen challenge for settlement talks
  • Horizon Therapeutics jumps as FTC withdraws in-house trial on $28B Amgen deal (update)
  • Seagen Tukysa combo breast cancer treatment successful in phase 3
PEERS
/XLV

XLV

Date Price Open High Low Vol Change ER
May 26, 2023 193.49 194.88
195.74
192.5
1.3M -0.49%
May 25, 2023 194.44 194.57
195.08
193.8
854K -0.5%
May 24, 2023 195.42 197.27
197.86
195.23
578K -0.54%
May 23, 2023 196.49 193.85
197.07
193.18
1.2M 1.62%
May 22, 2023 193.36 193.66
193.91
192.3
1.4M 0.03%
 
May 19, 2023 193.3 194.5
195.33
193.15
1.5M -0.44%
May 18, 2023 194.15 192.56
195.2
192.56
2.1M 0.57%
May 17, 2023 193.05 191.12
194.78
190.04
3.6M 2.88%
May 16, 2023 187.64 189.78
191.18
184.69
7.1M -5.97%
May 15, 2023 199.55 199.29
200.2
199
1.5M 0.28%
May 12, 2023 199 199.5
200.18
198.07
1.3M -0.25%
May 11, 2023 199.5 200.56
201
199.01
725K -0.25%
May 10, 2023 199.99 200.34
200.49
199.64
919K 0%
May 9, 2023 200 198.3
200.32
198.01
996K 0.89%
May 8, 2023 198.23 199.87
200.04
198.14
1.5M -0.82%
May 5, 2023 199.87 198.57
200.91
198.2
1.6M 0.69%
May 4, 2023 198.5 198.54
199.42
197.82
1.4M -0.04%
May 3, 2023 198.58 200.8
200.8
198.52
1.2M -0.68%
May 2, 2023 199.93 199.72
200.36
199.37
1.5M 0.39%
May 1, 2023 199.16 200.18
200.44
198.93
1.3M -0.42%
Apr 28, 2023 200 200.83
202
199.93
1.7M -0.38%
Apr 27, 2023 200.76 201.4
202.14
200.5
1.2M -0.31%
Apr 26, 2023 201.39 202.53
202.98
201
1.4M -0.89%
Apr 25, 2023 203.2 203.9
203.94
202.82
1.3M -0.03%
Apr 24, 2023 203.27 204.5
204.5
203.16
1.6M -0.26%
Apr 21, 2023 203.8 204.95
205.23
203.5
1.1M -0.24%
Apr 20, 2023 204.29 205.31
205.45
204.14
1.1M -0.35%
Apr 19, 2023 205 204.76
205.4
204.68
1.1M 0%
Apr 18, 2023 205 205.15
205.6
204.65
1.2M -0.19%
Apr 17, 2023 205.4 206.35
206.35
205.1
1.1M -0.05%
Apr 14, 2023 205.5 205.1
206.89
204.91
2.1M -0.36%
Apr 13, 2023 206.25 205.1
207.16
205.1
1.3M 0.51%
Apr 12, 2023 205.2 205.4
205.75
205
1.0M 0.11%
Apr 11, 2023 204.98 205
205.5
204.46
2.0M 0.14%
Apr 10, 2023 204.7 204.52
205.05
203.49
2.0M -0.41%
Apr 6, 2023 205.55 205.77
206.38
204.9
2.0M 0.27%
Apr 5, 2023 205 205
206.24
204.79
2.1M 0.05%
Apr 4, 2023 204.89 202.65
205
202.38
1.3M 1.43%
Apr 3, 2023 202 203.41
203.5
199.75
1.7M -0.23%
Mar 31, 2023 202.47 203.01
204.41
201.77
1.4M -0.3%
Mar 30, 2023 203.08 203
203.61
202.68
1.3M 0.42%
Mar 29, 2023 202.23 202.55
203.65
201.59
1.3M -0.39%
Mar 28, 2023 203.02 199.6
203.19
199.5
1.3M 1.71%
Mar 27, 2023 199.6 199.1
200.85
199.04
1.9M 0.99%
Mar 24, 2023 197.64 198.1
198.3
196.93
791K -0.23%
Mar 23, 2023 198.1 199.43
199.71
197.98
895K -0.14%
Mar 22, 2023 198.37 200.69
200.69
198.37
819K -0.77%
Mar 21, 2023 199.91 200.41
201.14
199.77
1.0M -0.25%
Mar 20, 2023 200.41 200
200.69
199.3
1.0M 0.05%
Mar 17, 2023 200.3 199.98
201.04
199.65
1.8M -0.09%
Mar 16, 2023 200.48 199.9
200.78
198.59
1.8M 0.27%
Mar 15, 2023 199.94 199.98
200.65
199.38
2.2M 0.05%
Mar 14, 2023 199.84 199
200.1
197.56
2.8M 1.11%
Mar 13, 2023 197.65 198.75
202.86
196.87
9.3M 14.51%
Mar 10, 2023 172.61 173.64
173.98
169.13
1.1M -0.59%
Mar 9, 2023 173.64 176.3
177.81
173.45
1.2M -1.54%
Mar 8, 2023 176.36 177.51
177.51
174.72
521K -0.64%
Mar 7, 2023 177.5 177.96
179.89
177.17
992K 0.08%
Mar 6, 2023 177.35 180.05
180.06
176.22
1.1M -2.17%
Mar 3, 2023 181.29 179.12
182.48
177.44
1.1M 0%